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ABSTRACT

Electrospray ionization mass spectrometry (ESI-MS) was assessed as a tool for the
analysis of different glycosylated and iron forms of transferrin (tf). Carbohydrate
deficient transferrin (CDT) is clinically relevant in the diagnosis of congenital disorders
of glycosylation (CDG) and in monitoring compliance in rehabilitation programs for
alcoholism.

The iron load of transferrin is an indicator of iron deficiency (or

sufficiency). The concentration ranges (5 – 15 µM) over which the ESI-MS response
for tf was λινεαρ were determined in 0.1 M NH4HCO3, pH 8.2, and in 1% formic acid.
In order to develop a method for analysis by ESI-MS, optimal conditions were
determined for obtaining CDT from commercial apo-tf by treatment with neuraminidase
or PNGase. The resulting CDT forms were separated by HPLC and analysed by ESIMS. The abundant human serum albumin was removed from plasma by loading 25-75

µl of plasma onto a Micro Bio-Spin column containing Cibacron Blue-agarose. A high
quality ESI mass spectrum of tf was obtained from the eluent. Using ESI-MS it was
possible to distinguish between commercial holo-tf (Fe2-tf) and apo-tf (Fe0-tf). The
rapid analysis of transferrin from plasma by ESI-MS lays the foundation for
development of a clinical method for analysing CDT and possibly for determining the
iron load of circulating tf.
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